Giuseppe Rosano (@gmcrosano) 's Twitter Profile
Giuseppe Rosano

@gmcrosano

Professor of Cardiology, Past-president Heart Failure Association
#ImprovingHeartFunction

ID: 1521222916368736256

linkhttps://www.iheartfunction.com/ calendar_today02-05-2022 20:19:56

192 Tweet

808 Followers

106 Following

Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

Sudden cardiac arrest and WCD therapies David Duncker provides insights into this large-scale German study that included 19,000 patients recently diagnosed with non-ischemic cardiomyopathy or myocardial infarction and equipped with a wearable cardioverter defibrillator (WCD).

Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

GDMT and LVEF: from static measure to trajectories of change Journal Club review📷 shorturl.at/NVQeQ The clinical paradigm that relies on a static measurement of #LVEF to categorize and manage heart failure is increasingly recognized as reductive. There is a growing need

GDMT and LVEF: from static measure to trajectories of change

Journal Club review📷 shorturl.at/NVQeQ

The clinical paradigm that relies on a static measurement of #LVEF to categorize and manage heart failure is increasingly recognized as  reductive. There is a growing need
Heart Success Foundation (@heartsuccessf) 's Twitter Profile Photo

Meet Professor Giuseppe Rosano! Giuseppe brings to the table three decades of experience in the field of cardiology. When asked why he supports our initiative, he shared, “we need to enable developing countries to deliver optimal care with the resources they have available.”

Meet Professor Giuseppe Rosano! Giuseppe brings to the table three decades of experience in the field of cardiology. When asked why he supports our initiative, he shared, “we need to enable developing countries to deliver optimal care with the resources they have available.”
Int Society of Nephrology (@isnkidneycare) 's Twitter Profile Photo

We are thrilled to announce the publication of a new collaborative paper released today: “Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: A Call to Action From the Cardio-Kidney Community.” 🧾 Read the full publication:

We are thrilled to announce the publication of a new collaborative paper released today:
 “Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: A Call to Action From the Cardio-Kidney Community.”

🧾 Read the full publication:
Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

🎥 #ICYMI: This #EuroPCR session with #ImprovingHeartFunction dives into the value of coordinated care in complex #HeartFailure cases. 👨‍⚕️ A 69-year-old with severe LV dysfunction & mitral regurgitation is at the heart of the discussion. @Pcronline 🔓 Watch free⬇️

Jan Biegus (@janbiegus) 's Twitter Profile Photo

👋 Dear Colleagues and Friends, Please take 5 minutes ⏳ to complete the survey on HF pharmacotherapy 💊❤️. Every response is highly appreciated 🙏. Thank you very much! 😊 docs.google.com/forms/d/e/1FAI… Javed Butler Marco Metra HFAPresident Giuseppe Rosano Piotr Ponikowski

HFAPresident (@hfa_president) 's Twitter Profile Photo

🫀 Managing #HeartFailure across the LV function spectrum? Join the #HFA_ESC webinar: 🎓 Treatment of Heart Failure Across the LV Function Continuum 📌 18 June 2025 📌 18:00–19:00 CET Faculty: Prof Theresa McDonagh , Dr #AntonioBayesGenis & Prof #LarsKober 🔗 Register now:

🫀 Managing #HeartFailure across the LV function spectrum?

Join the #HFA_ESC webinar:
🎓 Treatment of Heart Failure Across the LV Function Continuum
📌 18 June 2025
📌 18:00–19:00 CET

Faculty: Prof <a href="/TheresaMcDonag3/">Theresa McDonagh</a> , Dr #AntonioBayesGenis &amp; Prof #LarsKober

🔗 Register now:
Giuseppe Rosano (@gmcrosano) 's Twitter Profile Photo

Don't miss this webinar - we'll see you online at 6pm today for a transdisciplinary discussion about #GDMT optimisation in #HFrEF. #ImprovingHeartFunction #heartfailure

Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

⌛Happening this Thursday, 19 June at 18:00 CET! A new #ImprovingHeartFunction webinar on fast-track #GDMT optimisation in HF patients with functional MR. Join Emanuele Barbato, Giuseppe Rosano, Philipp Lurz and Alexandre Mebazaa for a live discussion. Free

⌛Happening this Thursday, 19 June at 18:00 CET!

A new #ImprovingHeartFunction webinar on fast-track #GDMT optimisation in HF patients with functional MR.

Join Emanuele Barbato, <a href="/GMCRosano/">Giuseppe Rosano</a>, <a href="/PhilippLurz/">Philipp Lurz</a> and <a href="/AlexMebazaa/">Alexandre Mebazaa</a>  for a live discussion.

Free
Heart Success Foundation (@heartsuccessf) 's Twitter Profile Photo

Just wrapped up an inspiring two days at the Heart Failure Forum 2025 in Dubai🫀 Truly impressive to see such a strong lineup of global experts sharing insights and advancing the conversation on heart failure care. 👏 #HFF2025 #HeartFailure #Cardiology #DubaiEvents #HeartHealth

Just wrapped up an inspiring two days at the Heart Failure Forum 2025 in Dubai🫀
Truly impressive to see such a strong lineup of global experts sharing insights and advancing the conversation on heart failure care. 👏
#HFF2025 #HeartFailure #Cardiology #DubaiEvents #HeartHealth
Amelia Carro — Instituto Corvilud (@icorvilud) 's Twitter Profile Photo

CARDIAC RHYTHM DEVICES IN HEART FAILURE ✍️Expert consensus document DIRECT-HF initiative #ESC_HF ✍️Role, timing,optimal use in contemporary practice ✍️Patient-centred managementof #HFrEF ✍️Integration of implantable device therapy in comprehensive #HF care doi.org/10.1002/ejhf.3…

CARDIAC RHYTHM DEVICES IN HEART FAILURE
✍️Expert consensus document DIRECT-HF initiative #ESC_HF
✍️Role, timing,optimal use in contemporary practice
✍️Patient-centred managementof #HFrEF
✍️Integration of implantable device therapy in comprehensive #HF care
doi.org/10.1002/ejhf.3…
Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

🚫Therapeutic impasse? Not anymore. Refractory heart failure is becoming a catalyst for change — in strategy, in collaboration, and in outcomes. 🔍 Emanuele Barbato & Alexandre Mebazaa dive into the power of combining pharmacological advances with device-based therapies in a

🚫Therapeutic impasse? Not anymore.
Refractory heart failure is becoming a catalyst for change — in strategy, in collaboration, and in outcomes.

🔍 <a href="/EmanueleBarba13/">Emanuele Barbato</a>  &amp; <a href="/AlexMebazaa/">Alexandre Mebazaa</a> dive into the power of combining pharmacological advances with device-based therapies in a
HFAPresident (@hfa_president) 's Twitter Profile Photo

💧Fluid restriction in #HeartFailure, myth or must? Current guidelines offer limited evidence & FRESH-UP study fills the gap with real-world data on fluid & sodium strategies Join our #HFA_ESC Journal Club and: ✔️Understand the rationale, study design & findings ✔️Discuss

💧Fluid restriction in #HeartFailure, myth or must?

Current guidelines offer limited evidence &amp; FRESH-UP study fills the gap with real-world data on fluid &amp; sodium strategies

Join our #HFA_ESC Journal Club and:
✔️Understand the rationale, study design &amp; findings
✔️Discuss
Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

🆕 New Journal Club! Jolie Bruno, M.D. & Alexandre Mebazaa Mebazaa break down the CONFIDENCE trial (published in the NEJM): 💊 Finerenone + Empagliflozin in CKD + T2D. 📖Study insights & results here👉bit.ly/45NrJMY

🆕 New Journal Club! <a href="/Jolie_Bruno_/">Jolie Bruno, M.D.</a>  &amp; <a href="/AlexMebazaa/">Alexandre Mebazaa</a>  Mebazaa break down the CONFIDENCE trial (published in the <a href="/NEJM/">NEJM</a>):
💊 Finerenone + Empagliflozin in CKD + T2D.

📖Study insights &amp; results here👉bit.ly/45NrJMY